A new oral analgesic without the health risks associated with existing pain relievers has been proven safe. According to the drug’s developers, it could revolutionize pain management, especially for ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Use of interscalene block during total shoulder ...

SAN FRANCISCO--(BUSINESS WIRE)--Concentric Analgesics, Inc., a clinical-stage biopharmaceutical company developing novel, non-opioid pain therapeutics, today announced publication of a multicenter, ...

Glycine is a major inhibitory neurotransmitter that reduces nerve activity, helping to regulate pain signals, motor control and sensory processing. Glycine transporter 2 (GlyT2) is a key regulator of ...

The FDA defines acute pain as pain, lasting up to 30 days, typically in response to some form of tissue injury, such as trauma or surgery. In an effort to further combat the opioid crisis, the Food ...

In a recent study posted to the medRxiv* preprint server, University of Arizona researchers assessed the relationship between antibody responses and analgesic usage after coronavirus disease 2019 ...

Minority patients with acute abdominal pain are less likely to receive analgesic medications, compared to their white counterparts, new American research demonstrates. New research indicates that ...